ArticleInternational journal of cancer2017

ADCC employing an NK cell line (haNK) expressing the high affinity CD16 allele with avelumab, an anti-PD-L1 antibody.

Caroline Jochems et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.